Literature DB >> 23430912

Unusual cardiac "masses" in a newborn with infantile pompe disease.

Daniel T Swarr1, Beth Kaufman, Mark A Fogel, Richard Finkel, Jaya Ganesh.   

Abstract

Glycogen storage disease type II (OMIM #232300), or Pompe disease, may present in the newborn period with moderate-to-severe biventricular hypertrophy with or without left ventricular outflow tract obstruction that typically leads to death from cardiorespiratory failure in the first year of life. Glycogen deposition tends to be uniform, and is only occasionally accompanied by patchy areas of fibrosis. Here, we present an infant identified with biventricular hypertrophy and cardiac masses by prenatal ultrasound. Postnatal molecular studies did not support the diagnosis of tuberous sclerosis in this case. Additional evaluation for infantile hypertrophic cardiomyopathy confirmed the diagnosis of Pompe disease. We discuss whether the "cardiac masses," which brought this infant to medical attention and facilitated an early diagnosis of Pompe disease, may represent an unusual manifestation of GSD type II or the coincidental occurrence of an unrelated disease process.

Entities:  

Year:  2011        PMID: 23430912      PMCID: PMC3509919          DOI: 10.1007/8904_2011_85

Source DB:  PubMed          Journal:  JIMD Rep        ISSN: 2192-8304


  12 in total

1.  CARDIAC PROBLEMS IN THE GLYCOGENOSES WITH SPECIFIC REFERENCE TO POMPE'S DISEASE.

Authors:  A R HOHN; C U LOWE; J E SOKAL; E C LAMBERT
Journal:  Pediatrics       Date:  1965-02       Impact factor: 7.124

2.  A retrospective, multinational, multicenter study on the natural history of infantile-onset Pompe disease.

Authors:  Priya S Kishnani; Wuh-Liang Hwu; Hanna Mandel; Marc Nicolino; Florence Yong; Deyanira Corzo
Journal:  J Pediatr       Date:  2006-05       Impact factor: 4.406

3.  Use of cardiac magnetic resonance imaging to evaluate cardiac structure, function and fibrosis in children with infantile Pompe disease on enzyme replacement therapy.

Authors:  Piers C A Barker; Sara K Pasquali; Stephen Darty; Richard J Ing; Jennifer S Li; Raymond J Kim; Stephanie DeArmey; Priya S Kishnani; Michael J Campbell
Journal:  Mol Genet Metab       Date:  2010-07-23       Impact factor: 4.797

4.  Echocardiographic findings in Pompe's disease with left ventricular obstruction.

Authors:  Y Shapir; N Roguin
Journal:  Clin Cardiol       Date:  1985-03       Impact factor: 2.882

Review 5.  Comprehensive mutation analysis of TSC1 and TSC2-and phenotypic correlations in 150 families with tuberous sclerosis.

Authors:  A C Jones; M M Shyamsundar; M W Thomas; J Maynard; S Idziaszczyk; S Tomkins; J R Sampson; J P Cheadle
Journal:  Am J Hum Genet       Date:  1999-05       Impact factor: 11.025

6.  Mutational analysis of the TSC1 and TSC2 genes in a diagnostic setting: genotype--phenotype correlations and comparison of diagnostic DNA techniques in Tuberous Sclerosis Complex.

Authors:  Ozgur Sancak; Mark Nellist; Miriam Goedbloed; Peter Elfferich; Cokkie Wouters; Anneke Maat-Kievit; Bernard Zonnenberg; Senno Verhoef; Dicky Halley; Ans van den Ouweland
Journal:  Eur J Hum Genet       Date:  2005-06       Impact factor: 4.246

7.  High rate of mosaicism in tuberous sclerosis complex.

Authors:  S Verhoef; L Bakker; A M Tempelaars; A L Hesseling-Janssen; T Mazurczak; S Jozwiak; A Fois; G Bartalini; B A Zonnenberg; A J van Essen; D Lindhout; D J Halley; A M van den Ouweland
Journal:  Am J Hum Genet       Date:  1999-06       Impact factor: 11.025

8.  Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs.

Authors:  S L Dabora; S Jozwiak; D N Franz; P S Roberts; A Nieto; J Chung; Y S Choy; M P Reeve; E Thiele; J C Egelhoff; J Kasprzyk-Obara; D Domanska-Pakiela; D J Kwiatkowski
Journal:  Am J Hum Genet       Date:  2000-12-08       Impact factor: 11.025

9.  Genotype/phenotype correlation in 325 individuals referred for a diagnosis of tuberous sclerosis complex in the United States.

Authors:  Kit Sing Au; Aimee T Williams; E Steve Roach; Lori Batchelor; Steven P Sparagana; Mauricio R Delgado; James W Wheless; James E Baumgartner; Benjamin B Roa; Carolyn M Wilson; Teresa K Smith-Knuppel; Min-Yuen C Cheung; Vicky H Whittemore; Terri M King; Hope Northrup
Journal:  Genet Med       Date:  2007-02       Impact factor: 8.822

10.  Echocardiographic evidence of outflow tract obstruction in Pompe's disease (glycogen storage disease of the heart).

Authors:  A Rees; F Elbl; K Minhas; R Solinger
Journal:  Am J Cardiol       Date:  1976-06       Impact factor: 2.778

View more
  2 in total

1.  A Newborn with Infantile-Onset Pompe Disease Improving after Administration of Enzyme Replacement Therapy: Case Report.

Authors:  Meltem Bor; Ozkan Ilhan; Evren Gumus; Solmaz Ozkan; Meryem Karaca
Journal:  J Pediatr Intensive Care       Date:  2020-07-15

2.  Infantile Pompe disease: A case report and review of the Chinese literature.

Authors:  Yun Liu; Yang Yang; Beibei Wang; Lizhi Wu; Honglu Liang; Qing Kan; Zhaolan Cao; Youyan Zhao; Xiaoyu Zhou
Journal:  Exp Ther Med       Date:  2015-11-12       Impact factor: 2.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.